Latest news
{{'Thu, 26 Mar 2026 19:52:00 -0400' | dateFormatUsFilter}}
FDA approves Novo Nordisk's Awiqli®, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
Read more
{{'Thu, 19 Mar 2026 12:04:00 -0400' | dateFormatUsFilter}}
FDA approves Novo Nordisk’s new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile
Read more
{{'Tue, 10 Mar 2026 09:30:00 -0400' | dateFormatUsFilter}}
Novo Nordisk acknowledges receipt of Warning Letter and welcomes further dialogue with the US FDA
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.